Just a clarification @zilliqua: Atomo does not "produce" antigen tests; they procure them from Access Bio.
But yes, supply on other fronts has been noted as a key issue, hence the ongoing investment in infrastructure, blister machine and the like.
In a recent update, Atomo noted that their current production capacity (as well as the customer-centered nature of their product) has made them a more attractive option for multinational companies.
AT1 Price at posting:
23.0¢ Sentiment: Hold Disclosure: Held
